Article Information
History
- April 28, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Kevin R. Trabbic,
- Kristopher A. Kleski and
- Joseph J Barchi Jr.*
- Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702
- ↵*Address Correspondence to: Joseph J Barchi Jr, Head, Glycoconjugate and NMR Section, Chemical Biology Laboratory, Center for Cancer Research, 376 Boyles Street, Bldg 376, Rm 209, NCI Frederick, Frederick, MD 21702, 301-846-5905 (Voice), 301-846-6033 (FAX), barchij{at}mail.nih.gov
Posted April 28, 2021.
A Stable Nano-Vaccine for the Targeted Delivery of Tumor-Associated Glycopeptide Antigens
